Losers in Focus:Research in Motion Ltd, Celsion Corporation, InvenSense Inc, EnteroMedics Inc

Lakeway, TX -- (SBWIRE) -- 02/14/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Research In Motion Ltd (NASDAQ:BBRY) stock fell 7.96% to $13.99. Wells Fargo recently upgraded Research In Motion from Market Perform to Outperform and raised its valuation range from $11-$13 to $19-$20, in transferred coverage to analyst Maynard Um.

Additionally, the company, on Feb. 7, said it has named two telecom industry executives as directors, raising its board size to 12 members. The additions are Richard Lynch, retired executive vice president of Verizon Communications Inc., VZ -0.25% and Bert Nordberg, former chief executive of Sony Ericsson Mobile Communications.

How Should Investors Trade BBRY After The Latest Earnings Report? Find Out Here

Celsion Corporation (NASDAQ:CLSN) shares decreased 5.80% to $1.30. The company, on Feb. 5, announced that Zheijang HISUN Pharmaceutical Company (HISUN) does not plan to pursue the exclusive option to license ThermoDox® for the Greater China market. Accordingly, the parties will not enter into the exclusive license agreement, and Celsion will not receive nor will it require any future payment for the option or license, as contemplated in the Exclusive Option Agreement announced on January 22, 2013.

Is CLSN a Buy After The Solid Earnings? Get Free Trend Analysis Here

InvenSense Inc (NYSE:INVN) shares declined 5.07% to $14.03. The company, on Jan. 23, announced that it expect fourth quarter 2013 revenue, post- the holiday period, to be in a range of $52-$54 million. Analysts on an average were expecting the Company to report revenues of $53 million for the fourth quarter of 2013. The company designs and fabricates micro-electro-mechanical systems (MEMS) technologies.

How Should Investors Trade INVN After The Recent Movement? Find Out Here

EnteroMedics Inc (NASDAQ:ETRM) shares fell 3.91% and closed at $1.23. The company, on Feb. 13, announced financial results for the three months and full year ended December 31, 2012. For the full year ended December 31, 2012, the Company reported a net loss of $23.5 million, or $0.59 per share. For the three months ended December 31, 2012, the Company reported a net loss of $7.0 million, or $0.17 per share, including research and development expenses of $3.1 million and selling, general and administrative expenses of $3.6 million.

Get Latest News, Updates and Reports For Free On ETRM Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.